Squawk on the Street podcast

Cramer's Morning Take: Eli Lilly 4/30/24

0:00
3:48
Recuar 15 segundos
Avançar 15 segundos

Jim and Jeff discuss Eli Lilly after the company beat on quarterly profit and hiked its full-year guidance on strong sales of Mounjaro and Zepbound. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake  

CNBC Investing Club Disclaimer

 

 

Mais episódios de "Squawk on the Street"